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Gelapin, a degradable genipin cross-linked gelatin hydrogel
Abstract
The synthesis of genipin cross-linked gelatin (Gelapin) hydrogel materials is presented. Gelapin hydrogels
were comprehensively characterised through chemical, mechanical and physical analysis techniques. It
was found that the hydrogels could be cross-linked to up to 90% using a genipin concentration of 24.4%
(w/ w). The hydrogels reach a stable swollen state and cease leaching of residual starting materials after
72 h in phosphate buffered saline solution at 37 uC. The proteolytic degradation of Gelapin by
collagenase is tuneable through manipulation of the material composition with the rate of degradation
ranging from 60 mg per day up to 500 mg per day. The mechanical characteristics (at 37 uC) are
controllable through adjustment of the gelatin and genipin concentrations resulting in compressive
stress-at-failure values ranging from 26 kPa to 300 kPa. Gelapin gels were found to become more elastic
and ductile during proteolytic degradation up to 70% mass loss. The ability for vascularisation of these
hydrogels was demonstrated using a chick embryo chorioallantoic membrane assay method.
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The synthesis of genipin cross-linked gelatin (Gelapin) hydrogel materials is presented. Gelapin hydrogels
were comprehensively characterised through chemical, mechanical and physical analysis techniques. It was
found that the hydrogels could be cross-linked to up to 90% using a genipin concentration of 24.4% (w/
w). The hydrogels reach a stable swollen state and cease leaching of residual starting materials after 72 h
in phosphate buffered saline solution at 37 uC. The proteolytic degradation of Gelapin by collagenase is
tuneable through manipulation of the material composition with the rate of degradation ranging from 60
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mg per day up to 500 mg per day. The mechanical characteristics (at 37 uC) are controllable through
adjustment of the gelatin and genipin concentrations resulting in compressive stress-at-failure values
ranging from 26 kPa to 300 kPa. Gelapin gels were found to become more elastic and ductile during
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proteolytic degradation up to 70% mass loss. The ability for vascularisation of these hydrogels was
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demonstrated using a chick embryo chorioallantoic membrane assay method.

1. Introduction
The engineering of tissue and organs in a laboratory is a
comparatively cost effective and convenient alternative to
human tissue and organ donations. The tissue scaffold, i.e. the
material that reinforces the component’s structure, and holds
the cells in place during maturation, is a critical component of
all in vitro tissue engineering strategies.1 For engineering of
soft tissues, hydrogel materials are the most appropriate
scaffold materials because they have similar mechanical
properties and chemical composition to natural tissues.2,3
Hydrogels are a class of hydrated polymer materials whose
polymer fraction generally lies between 0.1%–10% (w/v), with
the remainder comprising of water or an aqueous solution.4
Typical examples of commercial hydrogel products include
toothpaste, foods, contact lenses, cosmetics, drug capsules
and medical creams and ointments. Over the past 30 years an
extensive array of both naturally derived and synthetic
hydrogels have been utilised in research and development
for all manner of tissue engineering objectives.2
The study and use of gelatin hydrogels dates back centuries
with the first documented use of gelatin materials for
a
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biomedical application as a hemostatic substance.5 Since then
it has also been utilised for surgical glues, sealants and wound
dressings.5–8 Gelatin is denatured, hydrolysed collagen which
itself is the primary constituent of all the connective tissues of
the human body (within skin, muscle, bones, cartilage, fat).9,10
It is produced commercially via acid and alkaline hydrolysis
and by proteolysis of collagen which can be derived from all
manner of organisms including, but not limited to: pigs, cows,
fish and rats.9,10 Depending on the type and extent of
hydrolysis/proteolysis and the originating species, different
gelatins can be produced with a variety of isoelectric points,
molecular weights and Bloom numbers (indicative of gel
strength).11 Gelatin hydrogels have the advantage of being
biocompatible, non-toxic, non-immunogenic and biodegradable as well as being cheap and readily available,12 making
them ideal candidate materials for biomedical applications.13
However, unmodified gelatin hydrogels are mechanically weak
and dissolve at temperatures above 29 uC which are limitations
that need to be addressed in order to develop them for
practical applications.9
It has been demonstrated that the mechanical and thermal
properties of gelatin hydrogels can be improved by crosslinking.14,15 Examples of reagents and methods used for crosslinking gelatin include chemical cross-linking with gluteraldehyde, formaldehyde, diisocyanates, carbodiimides and acyl
azides,16 as well as physical cross-linking using dehydrothermal treatment, ultraviolet irradiation and gamma irradiation.13 However, the physical treatments tend to achieve a very
limited extent of cross-linking, and the chemical treatments
have the potential to leave toxic residues in the gels which will
release upon biodegradation in vivo.13 Novel cross-linking
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reagents that are both effective and non-toxic are required to
improve the mechanical and thermal properties of gelatin
whilst retaining its inherent advantageous properties.
Genipin is a potent yet non-toxic cross-linker of proteins
such as chitosan, collagen and gelatin that has been recently
demonstrated to bestow anti-inflammatory properties to the
materials it is incorporated into.13,17–19 It is produced both
synthetically and naturally as the algycone of geniposide, an
iridoid glycoside that is the major component of the fruit of
the gardenia plant, Gardenia jasmindides Ellis.20 Genipin was
first proposed and demonstrated for use as a biological tissue
fixative and gluteraldehyde alternative in 1999 where it was
demonstrated to be 10 000 times less toxic and almost equally
efficacious.20 It has been established that genipin cross-linked
gelatin via the epsilon amino group present in lysine and
hydroxylysine residues (Fig. S1, ESI).21 Genipin has been used
in the preparation of cross-linked gelatin films and hydrogels,13,22–24 and employed in nerve guiding conduits, wound
dressings, and cartilage scaffolds.6,25,26
There is considerable interest in bioreactors for tissue
engineering that can culture three-dimensional constructs in a
dynamic fashion, and can also perfuse scaffold materials and
stimulate their contents mechanically.27–33 In particular,
mechanical stimulation has been shown to be crucial in
directing the differentiation and phenotype of many cell types
towards phenotypes which can produce a functional extracellular matrix which will ultimately replace the scaffold and
form the bulk of the new tissue component.31,32,34–38 In
consideration of this aspect of tissue engineering, it is
obviously of benefit to have a thorough understanding of the
mechanical and rheological properties of candidate materials.
In this paper, the preparation and characterisation of
genipin cross-linked gelatin (Gelapin) is presented. The ability
of genipin to act as a gelatin cross-linker was investigated,
including the stability and retention of both gelatin and
genipin in phosphate buffer saline solution at 37 uC. The
degradation behaviour and mechanical characteristics of these
hydrogels at 37 uC are discussed in detail and their ability for
vascularisation is demonstrated.
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magnetic stirrer/hot plate (Stuart CB162, UK). Subsequently,
the appropriate amount of 20.3% (w/v) genipin in 60% (v/v)
ethanol (Ajax Finechem, Australia) solution was added and
stirred for a further 3 min at 50 uC. The hot solution was then
poured into glass Petri dishes (60 mm diameter 6 15 mm
height, Schott, Australia) and allowed to cure for 24 h at 21 uC.
Silanisation of the Petri dishes with Coatasil (Thermofisher
Scientific, Australia) prior to use facilitated the easy removal of
the hydrogels without damaging them.
2.2 Extent of cross-linking
The extent of cross-linking in Gelapin hydrogels was determined by spectrophotometric comparison of the number of
epsilon amino groups present in cross-linked and uncrosslinked gelatin. The method used was based on the colorimetric
assay developed by Offner and Bubnis:39,40 Gelapin samples
were first lyophilised (LD Plus, Alpha, USA) and divided into
10–20 mg subsamples for individual analysis. Each subsample
was combined with 4 mL of 4% (w/v) NaHCO3 (Merck,
Australia), 1 mL of 0.5% (w/v) 2,4,6-trinitrobenzenesulfonic
acid (Sigma-Aldrich, USA) and heated in an oven (Binder-FD,
USA) for four hours at 40 uC. The subsamples were then
acidified with 3 mL of 6 M HCl (Ajax Finechem, Australia) and
hydrolysed in an autoclave (Tomy ES-315, 121 uC, 186 kPa, 20
min). Three extractions using 20 mL diethyl ether (BDH,
Belgium) were performed after addition of 5 mL of DI water. A
5 mL aliquot of the aqueous extract was taken, heated on a
steam bath for 15 min and allowed to cool to 20 uC for 18 h.
The samples were then made up to 20 mL and measured using
a dual beam spectrophotometer (Cary 500 Scan, Varian,
Australia) in 1 cm path length glass cuvettes at 346 nm.
The extent of cross-linking (EC) was determined by comparing the cross-linked blank corrected sample absorbance (A)
with the non-cross-linked blank corrected sample absorbance
(A0):
EC ~1{

A
:
A0

(1)

2.3 Swelling behaviour

2. Materials and methods
2.1 Preparation of hydrogels
All reagents used were AR grade unless otherwise stated and
deionised (DI) water (resistivity 18.2 MV cm) was prepared
using a combined ion exchange and osmosis filtration system
(Millipore, Australia). Gelapin hydrogels were prepared with
type A, porcine gelatin (Bloom number of 300, molecular
weight of 87 500 Da, Sigma-Aldrich, USA) with concentrations
of gelatin ranging 2%–10% (w/v) and genipin (Challenge
Bioproducts, Taiwan) concentrations ranging 0%–19.5% (w/w).
Throughout this report Gelapin hydrogels will be referred to
using nomenclature that describes their composition in the
format Gelapin-[gelatin %(w/v)]/[genipin %(w/w)]. A summary
of the preparation regime is as follows: Gelatin was initially
dissolved with gentle stirring in DI water at 50 uC on a
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Gelapin hydrogels were placed into round plastic containers
(60 mm diameter x 40 mm, Chanrol, Australia), filled with 40
mL of phosphate buffered saline (PBS) solution (pH = 7.4, 3
mM NaN3) and stored in a controlled temperature/humidity
chamber (TRH-150-SD, Thermoline, Australia) at 37 ¡ 1 uC for
up to 168 h. The samples were removed from the PBS
solutions, padded dry with filter paper, and weighed after 3,
6, 12, 24, 48, 72 and 168 h. The PBS solutions were replaced
with fresh PBS solutions at 24, 48 and 72 h. The swelling ratio
(SW) was calculated:
SW ~

Wt
|100%,
Wi

(2)

where Wi and Wt are the initial mass and the mass at different
swelling times, respectively.
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2.4 Genipin and gelatin leaching
Gelapin hydrogels were immersed in 40 mL PBS solution and
stored in sealed round container (60 mm diameter 6 40 mm,
Chanrol, Australia) at 40 uC for up to 72 h. At 24, 48 and 72 h,
the absorbance of the PBS solution (A24h, A48h and A72h,
respectively) was measured at 589 nm in the spectrophotometer in 1 cm glass cuvettes. After each 24 h period, the
hydrogels were re-immersed in fresh PBS solution. Although
the specific quantity of genipin could not be determined in
this way, the amount of genipin released relative to the total
leachable genipin (GR) was calculated as:
GR ~

At
|100%,
A24h zA48h zA72h

(3)

where At is the absorbance measured at either 24, 48 or 72 h.
At 24, 48 and 72 h, the gelatin concentration in the same
PBS solution was measured using a Coomassie Blue protein
assay kit (Coomassie Plus, Thermofisher Scientific, Australia)
in 96 well microplate format using a plate reader (Polarstar,
BMG Labtech, Germany) with an absorption spectrophotometer (595 nm). The gelatin concentration was calculated
from interpolation of the linear regression of a standard curve.
Calibration standards were prepared at gelatin concentrations
of 0, 75, 150, 300, 450, 750, 1125 and 1500 mg mL21 in
duplicate and samples were prepared in quadruplicate with
separate blanks.
2.5 Proteolytic and hydrolytic degradation
Gelapin hydrogels were preconditioned by soaking in PBS
solution in the temperature/humidity chamber at 37 ¡ 1 uC
for 14 days.
Hydrogel samples were placed into tissue cassettes (model
M512, Simport, Canada) before being immersed in either
collagenase solution for the proteolytic degradation study, or
PBS for the hydrolytic degradation study. The collagenase
solution was prepared from a lyophilized mixture of collagenases isolated from Chlostridium histolyticum (Sigma, USA) in
PBS to a concentration of 10 units mL21 of 2-furanacryloyl-Lleucylglycyl-L-prolyl-L-alanine (FALGPA). One unit of FALGPA
hydrolyses 1.0 mmole of FALGPA per min at 25 uC and pH 7.5
in the presence of calcium ions. The samples and solutions
were kept at 37 ¡ 1 uC for the duration of the study and had
the collagenase and PBS solutions changed regularly.
For each mass measurement, the samples in their cassettes
were removed from the collagenase/PBS solution, dried and
then weighed. The drying procedure involved drip-draining
the majority of the solution from the cassettes, followed by
blotting and wiping the solution away with tissue paper. The
mass of the samples (ms) were calculated by subtracting the
mass of the cassettes (mc) from the mass of the samples in
their cassettes (mt):
ms = mt 2 mc.

(4)

The extent of degradation (D) was calculated every 24 h as:


mt
D~ 1{
|100%,
(5)
mi
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where mt is the mass of the sample at a particular point in time
and mi is the initial mass. The degradation rate and the
induction period were determined from the slope and the
intercept of the steady-state region in a plot of the extent of
degradation versus time.
2.6 Rheological properties
The rheological properties of Gelapin hydrogels were examined using a rheometer (Physica MCR-301, Anton Paar,
Australia) with a Peltier temperature controlled bottom platen
and 15.0 mm parallel plate measuring system. All measurements were conducted at 37.0 ¡ 0.1 uC with 15.0 mm diameter
samples; a gap length of 1.00 ¡ 0.01 mm and 1.0 ¡ 0.1 N of
normal force. The following experiments were conducted
sequentially (with at least one minute rest between experiments): a strain-sweep experiment, where the oscillating
frequency was held constant at 1 Hz and the oscillating strain
was varied from 0.01% up to 10%; a frequency-sweep
experiment, where the oscillating strain was held constant at
0.05% and the oscillating frequency was varied from 0.8 Hz–80
Hz; a creep recovery experiment, where samples were
subjected to a non-oscillating shear stress of 10 Pa for a
period of 5 s and then allowed to relax. The linear viscoelastic
(LVE) region was defined in these experiments as the strain for
which the storage modulus deviates by more than 5% of the
initial (low strain) value.
2.7 Compressive mechanical properties
The mechanical properties of the full compositional range of
Gelapin hydrogels was assessed using a universal mechanical
analyser (EZ-S, Shimadzu, Japan). Prior to analysis, the
hydrogels were immersed in PBS solution within the temperature/humidity chamber 37 ¡ 1 uC for 72 h. The instrument
was adapted to incorporate a heated bath of PBS solution held
at 37 ¡ 2 uC, so that samples were immersed during analysis.
These compression tests were performed at a strain rate of 3
mm min˜1 with samples that had been cut with a scalpel to a
rectangular prism geometry of y10 mm 6 10 mm 6 8 mm.
Stress-strain data was used to determine the compressive
failure strain (emax), compressive tangent modulus over 20%–
30% strain (Etan), compressive failure stress (smax) and
compressive strain energy to failure (U).
The mechanical properties of Gelapin hydrogels with
composition of 4% (w/v) gelatin and 9.7% (w/w) genipin were
assessed during degradation via collagenase proteolysis. Prior
to testing, hydrogels (20 mm diameter, 5 mm height) were
allowed to equilibrate in PBS solution followed by immersion
in the collagenase solution. Partially degraded samples were
removed at regular intervals during the proteolytic degradation process and subjected to compressive mechanical testing.
2.8 Angiogenesis
To examine the ability of blood vessels to intrude into Gelapin
hydrogels and form nascent blood vessels the chick chorioallantoic membrane (CAM) on-plant assay was conducted
which utilises the highly vascularised CAM as an experimental
model of angiogenesis in situ.41 Grey rooster/white hen crossbred fertile chicken eggs (Barter and Sons Hatchery, Australia)
were incubated (HERAcell, Kendro Laboratory Products,
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Germany) for three days at 38 uC and 60% relative humidity
before separation of the shell from the embryo, yolk and
albumin. The embryo was then incubated (37.8 uC, 5% CO2)
for a further three days before Gelapin on-plants were laid
upon the surface of the vitelline. The embryos were then
returned to incubate for a further four days, during which
evidence of angiogenesis was monitored via optical microscopy (Z16, Leica, Germany).
Gelapin-6/9.7 on-plants were prepared in the absence
(control) and presence of 0.5 mM phorbol-12-myristate-13acetate (PMA) as a chemical stimulator of angiogenesis
(Cayman Chemical, USA).42 Partially cured gels were then
dispensed into the cavity of the on-plant device consisting of
the space between two 5 mm squares of sterile mesh (Nylon6,6, 180 mm grid size, 47% open area, Sefar Pty Ltd, Australia)
and a spacer (Nylon-6,6, internal diameter 5.3 mm, external
diameter 11.0 mm, 1.0 mm thickness, RS Components Pty Ltd,
Australia). The gels were then allowed to cure and solidify over
4 more hours before being immersed in PBS solution and
rested for an additional 18 h to allow uncross-linked genipin
to leach out and for the gel to shrink to its equilibrium size.
Macroscopic images were taken with a digital camera
(Lumix DMC-FT1, Panasonic, Japan). Microscopic images were
taken with the microscope with attached digital camera (DFC290, Leica, Germany). Image analysis was performed with the
Leica Application Suite (Leica, Germany). Assessment of the
extent of angiogenesis, both in and around the on-plants were
made on the basis of the number of blood vessels intersecting
the on-plant boundary at 60u–120u in a spherical area with
radius 10 mm from the centre of the on-plant. Other
qualitative assessments were also made by inspecting above
and below the on-plants and measuring the range and
thickness of the surrounding blood vessels.
2.9 Statistical treatment of data
Dixon’s Q-test (95% confidence) was used to confirm and
justify the removal of spurious data. Unless otherwise stated,
the data presented in this manuscript are the mean ¡ one
standard deviation (SD).
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Fig. 1 Extent of cross-linking in Gelapin hydrogels as a function of genipin
concentration. Diamonds, squares and triangles represent gelatin concentrations of 2%, 5% and 10% (w/v), respectively.

Our results are in agreement with those of Bigi and coworkers,13 who suggested that genipin is unable to attain
100% EC due to a shielding effect of the gelation tertiary
structure, which prevents some of the lysine residues from
reacting with genipin. Smaller and more flexible cross-linking
molecules, such as gluteraldehyde have been reported to attain
a maximum EC of 100%.16 Notwithstanding, genipin should
still be considered an effective cross-linker of gelatin,
especially when one considers that it has been demonstrated
that genipin is not cytotoxic20,43 and bestows anti-inflammatory character.18,19
3.2 Swelling behaviour
The swelling ratio of Gelapin hydrogels was observed to be
dependent on both the gelatin concentration and the crosslinker concentration (Table S1, ESI3). The swelling profiles of
all hydrogels could be described as an initial rapid decrease in
size which slowed to a steady state where no further significant
change in mass occurred (an example profile for the Gelapin10/X hydrogels is presented in Fig. 2). The hydrogels all exuded
water to varying extents, dependant on their composition

3. Results and discussion
3.1 Extent of cross-linking
Hydrogels were prepared by cross-linking gelatin with genipin.
The extent of cross-linking (EC) is a measure of the effectiveness of genipin as the cross-linker for gelatin and was used to
determine the amount of genipin required to obtain specific
amounts of cross-linking in all subsequent experiments. The
EC ratio presents the percentage of cross-linking sites in
gelatin that form part of a cross-link versus the total amount of
potential cross-linking sites and is calculated as described in
eqn (1). The ratio was found to increase with increasing
genipin concentration (Fig. 1). The maximum extent of crosslinking attainable for Gelapin hydrogels was observed to be
84%–90% for all concentrations of gelatin examined. This data
can be used to predict the concentration of genipin required to
attain any EC desired or vice-versa.

1076 | RSC Adv., 2013, 3, 1073–1081

Fig. 2 Swelling ratio as a function of time for typical Gelapin hydrogels with
gelatin concentration of 10% (w/v). Diamonds, squares, triangles and crosses
indicate genipin concentrations of 4.9, 7.3, 12.2 and 19.5% (w/w), respectively.
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(Table S1, ESI3). For 2%, 3% and 4% (w/v) gelatin hydrogels it
took 48 h of soaking before the equilibrium swelling state was
reached. For 5% and 10% (w/v) gelatin hydrogels, it took 72 h
to reach the equilibrium swelling state. The extent of deswelling was found to be inversely proportional to the gelatin
concentration and directly proportional to the genipin
concentration. This behaviour is consistent with the Flory–
Rehner theory where hydrogel volume is affected by the
balance between osmotic pressure and elastic restorative
forces.44 Hydrogels which contain more gelatin possess a
greater osmotic pressure which acts to draw water into the gels
and increases the equilibrium volume, while those with more
extensive cross-linking possess a greater elastic restorative
force which decreases the volume at equilibrium.
Some Gelapin hydrogels were not physically stable in
simulated physiological conditions, PBS solution at 37 uC
and pH 7.4. Hydrogels compositions comprising of 2% (w/v)
gelatin and less than 7.3% (w/w) genipin; 3% (w/v) gelatin and
less than 4.9% (w/w) genipin; and 4% (w/v) gelatin with 2.4%
(w/w) genipin, dissolved completely over 24 h of soaking.
These hydrogels possess relatively low concentrations of
gelatin and genipin and therefore possess only a small
amount of polymer entanglement and covalent cross-links. It
is suggested that this causes them to dissolve when the
temperature of the hydrogels is raised from the curing
temperature (y20 uC) to the temperature (37 uC) at which all
testing is carried out.
It is well known that proteinaceous hydrogels, such as
Gelapin are particularly sensitive to changes in pH which
affect the balance of charges on the polymeric backbone.44
This was demonstrated by investigating the swelling behaviour
in PBS soaking solutions (at 37 uC) of pH 8.2. Under these
conditions it was observed that the SW was higher compared to
the corresponding gels swollen in PBS at pH 7.4.
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demonstrate that by increasing the amount of cross-linking,
the gelatin release can be slowed or extinguished altogether.
3.4 Proteolytic and hydrolytic degradation
The extent of proteolytic and hydrolytic degradation (D) of
Gelapin hydrogels were obtained using mass measurements of
samples immersed in PBS solution with and without collagenase, respectively, over 93 days. Samples of hydrogel which
had been immersed with collagenase were observed to lose
mass at three different rates (Fig. 3a, Table 1), referred to as
the initial, steady state and tailing periods. In the initial
(induction) period the infiltration of the hydrogel by collagenase commences and it begins to make scissions in the

3.3 Genipin and gelatin leaching
Gelapin hydrogels were immersed in PBS solution at 37 uC and
pH 7.4 for several days during which the leaching of genipin
and gelatin were monitored regularly. A noticeable amount of
genipin in the form of partially reacted (not cross-linked) blue
genipin pigments was observed to leach from the Gelapin
hydrogels during 72 h of immersion in PBS solution. The blue
pigments are commonly known as the edible blue food dye
‘‘Gardenia Blue’’ and are a result of interactions between
genipin and gelatin.17 The percentage of genipin released (GR)
was calculated according to eqn (3) at 24 h, 48 h and 72 h (data
not shown). It was observed that the majority (.89%) of the
genipin was released during the first 24 h for all of the Gelapin
hydrogels.
Insignificant amounts of gelatin were released from Gelapin
hydrogels whilst being immersed in PBS (Table S2, ESI3). The
majority of the gelatin was released within the first 24 h of
soaking with no detectable amount being released on
subsequent days. The amount released was inversely proportional to the extent of cross-linking. This is likely to be a result
of cross-links tethering gelatin molecules together as well as
contributing to confinement and entanglement of noncovalently cross-linked gelatin molecules. This initial release
may represent the superficial, unbound gelatin. These results

This journal is ß The Royal Society of Chemistry 2013

Fig. 3 (a) Typical proteolytic degradation profile for Gelapin-8/14.6. (i-iii)
indicate the three period of the degradation, i.e. induction, steady state and
tailing, respectively. (b) Proteolytic degradation rates of Gelapin hydrogels (¡
SD). (c) Degradation time for Gelapin hydrogels (¡ K range).
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Table 1 The induction times (tI), degradation rates (D) and degradation times
(tD) for proteolytic degradation and the hydrolytic mass change (DM) for
Gelapin hydrogels after a 93 day hydrolytic degradation period. The
nomenclature of Gelapin hydrogels describes their composition in the format
Gelapin-[gelatin %(w/v)]/[genipin %(w/w)]

Published on 13 November 2012. Downloaded by University of Wollongong on 14/07/2014 07:33:06.

Sample
Gelapin-2/14.6
Gelapin-2/19.5
Gelapin-4/4.9
Gelapin-4/9.7
Gelapin-4/14.6
Gelapin-4/19.5
Gelapin-6/4.9
Gelapin-6/9.7
Gelapin-6/14.6
Gelapin-6/19.5
Gelapin-8/4.9
Gelapin-8/9.7
Gelapin-8/14.6
Gelapin-8/19.5
Gelapin-10/4.9
Gelapin-10/9.7
Gelapin-10/14.6
Gelapin-10/19.5

Proteolytic
tI/days

D/mg per day tD/days

Hydrolytic
DM/%

1.01 ¡ 0.06
1.0 ¡ 0.2
0.07 ¡ 0.06
0.83 ¡ 0.09
1.3 ¡ 0.1
2.1 ¡ 0.3
0.09 ¡ 0.03
0.84 ¡ 0.07
1.4 ¡ 0.3
1.5 ¡ 0.3
0.0 ¡ 0.1
0.73 ¡ 0.07
1.4 ¡ 0.2
1.5 ¡ 0.3
0.0 ¡ 0.2
0.9 ¡ 0.2
2.0 ¡ 0.3
2.14 ¡ 0.05

400 ¡ 26
320 ¡ 17
520 ¡ 83
260 ¡ 33
180 ¡ 22
150 ¡ 22
360 ¡ 25
181 ¡ 9
120 ¡ 29
110 ¡ 12
240 ¡ 28
140 ¡ 13
94 ¡ 1
90 ¡ 12
210 ¡ 34
100 ¡ 15
74 ¡ 9
60 ¡ 3

22 ¡ 2
22 ¡ 2
+2.5 ¡ 0.6
+2.7 ¡ 0.2
+2.3 ¡ 0.2
+2.9 ¡ 0.3
+3.9 ¡ 0.3
+3.44 ¡ 0.06
+3.3 ¡ 0.2
+5.6 ¡ 0.5
+4.8 ¡ 0.4
+5.9 ¡ 0.2
+6.5 ¡ 0.4
+6.8 ¡ 0.5
+5.9 ¡ 0.1
+7.41 ¡ 0.07
+7.9 ¡ 0.2
+9.0 ¡ 0.3

3.5 ¡ 0.5
4¡0
3.5 ¡ 0.5
5¡0
8.5 ¡ 0.5
10.5 ¡ 0.5
6¡0
11 ¡ 1
15.5 ¡ 1.5
17.5 ¡ 1.5
9.5 ¡ 0.5
17.5 ¡ 1.5
22.5 ¡ 3.5
28.5 ¡ 3.5
13.5 ¡ 0.5
29.5 ¡ 1.5
44 ¡ 7
49 ¡ 3

gelatin. During this period the hydrogel was being degraded
but there was no significant change in mass loss until there
were enough scissions made in the matrix to dislodge
fragments from the bulk material. For samples immersed in
collagenase, the induction period was found to be proportional to the amount of cross-linking in the Gelapin hydrogels,
i.e. it was instantaneous for the least cross-linked hydrogels
and up to 2 days for the hydrogels with the highest degree of
crosslinking.
In the second (steady state) period, the degradation rate for
the hydrogels immersed in collagenase solution ranged from
60 mg per day up to 500 mg per day and was observed to be
dependent on both the gelatin concentration and the
concentration of the genipin (Fig. 3b). Increasing the gelatin
concentration increased the density of the hydrogel producing
a less penetrable matrix for collagenase and partially degraded
matrix to diffuse through. As a result, the degradation rate
observed for high gelatin content hydrogels was lower than
that of the low gelatin content hydrogels. Gels with higher
concentrations of the genipin cross-linker exhibited slower
degradation rates. It is suggested that the covalent cross-links
formed with genipin molecules are resistant to degradation by
collagenase and may be tying partially degraded gelatin
molecules together and contributing to their entanglement
for longer periods of time than less densely cross-linked
Gelapin hydrogels.
In the third (tailing) period, degradation rate decreased
until the entire material was degraded. During this period,
degradation is limited by the available surface area of the
sample which diminishes in proportion to the radius of the
sample squared. Consequently, as the sample is degraded to a
smaller size, the sample area and degradation rate decrease
quickly. The total time it took samples to degrade via
proteolysis ranged from 3.5 ¡ 0.5 to 49 ¡ 3 days and was
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proportional to the gelatin and genipin concentrations
(Fig. 3c). Slower degradation rates were observed for higher
gelatin content and more extensively cross-linked Gelapin
hydrogels which had a direct effect on the overall time taken to
degrade the component. In contrast, Gelapin hydrogel which
was not exposed to collagenase did not show significant signs
of degradation over 93 days, or a time period which is twice as
long as it took for the most robust Gelapin hydrogels to
degrade completely in collagenase. In fact, most samples
increased in mass by a small amount which may be a result of
swelling (Table 1). This suggests that in the absence of matrix
metalloproteases such as collagenase, Gelapin hydrogels will
not significantly degrade as a result of indiscriminate
hydrolysis.
3.5 Rheological properties
Strain-sweep experiments were conducted to identify the linear
viscoelastic (LVE) region which was observed to be up to 5%
shear strain (data not shown). Hydrogels which possess a
higher cross-linker concentration had shorter LVE regions as
compared with hydrogels with smaller cross-linker concentration, which can be explained by the stiffening effect of crosslinking. For example, the shear strain values for the limit LVE
region were 5% and 0.1% for Gelapin-4/4.9 and Gelapin-8/14.6
hydrogels, respectively. As expected, the values for the storage
and loss moduli were larger for gels with a higher degree of
cross-linking, consistent with a previous rheological study of
cross-linked hydrogels using pollock gelatin.23 For example,
Gelapin-4/4.9 and Gelapin-8/14.6 hydrogels exhibited storage
modulus values in the LVE region of 9 kPa and 90 kPa,
respectively. The data from the frequency-sweep and creep
recovery experiments indicated that the storage and loss
moduli of Gelapin hydrogels were independent on frequency
up to 80 Hz (data not shown).
3.6 Compressive mechanical properties
The mechanical properties of Gelapin hydrogels were examined in compression whilst immersed in PBS solution at 37 uC
(Fig. 4). Compressive strain at failure (emax) values varied
between 50 ¡ 3% and 74 ¡ 5% and were inversely
proportional with increasing concentration of genipin

Fig. 4 Typical stress-strain curves for, Gelapin-8/14.6 (line 1), Gelapin-6/9.7 (line
2) and Gelapin-4/4.9 (line 3).
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(Table 2). This can be explained by the increased density of
covalent cross-linking in the hydrogels induced by a higher
genipin concentration—with more covalent cross-links, comes
a greater amount of elastic stiffness reducing the extent of
deformation before the hydrogel fails. The gelatin concentration was also observed to have a similar effect on emax values.
The increased gelatin concentration is accompanied by more
polymer entanglement which acts as a comparatively weak
cross-link.
Tangent modulus (Etan) values were observed to increase
significantly with increasing concentration of genipin
(Table 2). Etan was also observed to be proportionate to the
gelatin concentration. It is suggested that these observations
are a result of increased polymer entanglement and physical
cross-link density. In other words, the gels are becoming stiffer
but less ductile with increasing genipin and gelation concentrations.
Compressive stress at failure (smax) values ranged between
26 ¡ 6 kPa and 300 ¡ 60 kPa in proportion to the gelatin
concentration. It is likely that this can be explained by
realising that gels with higher amounts of gelatin have a
higher overall density. Hence, they require more stress to
deformation to the point of failure (Table 2). The cross-linker
concentration (genipin) did not have a significant effect on
smax. Compressive strain energy at failure (U) values ranged
from 3 ¡ 1 kJ m23 to 50 ¡ 10 kJ m23, and increased with
increasing gelatin and genipin concentration. The compressive mechanical characteristics of our gels are in the same
order of magnitude as those reported for a gelatin scaffold
(100–140 kPa, cross-linked by immersion in a genipin
solution) developed for cartilage tissue engineering.26
Our results demonstrate that Gelapin hydrogels are a
versatile material which can have tuned mechanical properties
through careful control over the gelatin and genipin concen-

tration. Increasing the gelatin concentration increased the
overall strength and toughness as indicated by the compressive stress and strain energy to failure, while increasing the
genipin concentration increased the stiffness and toughness
and limited the maximum strain attainable as reflected by the
Etan, U and emax values.
The effect of degradation on the mechanical characteristics
was examined using a typical Gelapin hydrogel (Gelapin-4/9.7)
which was exposed to collagenase for up to 10 days. Fig. 5
shows that strain-at-break values increase, while tangent
modulus values increase during proteolytic degradation of
up to 70% (by mass). In other words, the gels become more
ductile and elastic as a result of the mass loss. Once the
hydrogels had degraded by 70%, they became too fragile to
handle and could not be subjected to mechanical testing.
3.8 Angiogenesis
Materials used as a tissue scaffold have traditionally relied
upon diffusion of nutrients and oxygen to provide nourishment and address the respiratory requirements of the cells
therein. However, diffusion is limited to only several hundred
microns in most cases and this presents a challenge for tissue
homeostasis.45 This can be overcome by promoting blood
vessel invasion into the scaffold.46 Vascularisation of Gelapin
hydrogels from existing vasculature was investigated using
the chick embryo CAM as an experimental model of
angiogenesis in situ. Gelapin-6/9.7 hydrogels materials were

Table 2 Summary of mechanical properties for Gelapin hydrogels. Compressive
strain at failure, compressive tangent modulus (20%–30% strain), compressive
stress at failure and compressive strain energy to failure are indicated by emax,
Etan, smax and U, respectively. The nomenclature of Gelapin hydrogels describes
their composition in the format Gelapin-[gelatin %(w/v)]/[genipin %(w/w)]

Sample

emax (%)

Gelapin-2/9.7
Gelapin-2/14.6
Gelapin-2/19.5
Gelapin-4/4.9
Gelapin-4/9.7
Gelapin-4/14.6
Gelapin-4/19.5
Gelapin-6/4.9
Gelapin-6/9.7
Gelapin-6/14.6
Gelapin-6/19.5
Gelapin-8/4.9
Gelapin-8/9.7
Gelapin-8/14.6
Gelapin-8/19.5
Gelapin-10/4.9
Gelapin-10/9.7
Gelapin-10/14.6
Gelapin-10/19.5

67
57
55
74
59
54
52
65
58
53
51
62
55
52
52
64
62
50
51

¡
¡
¡
¡
¡
¡
¡
¡
¡
¡
¡
¡
¡
¡
¡
¡
¡
¡
¡

7
5
7
5
5
2
5
6
5
5
5
5
6
3
5
6
8
3
5

Etan/kPa

smax/kPa

U/kJ m23

13 ¡ 6
22 ¡ 4
40 ¡ 10
18 ¡ 3
90 ¡ 20
130 ¡ 20
160 ¡ 30
50 ¡ 10
150 ¡ 30
200 ¡ 40
270 ¡ 40
170 ¡ 20
250 ¡ 50
320 ¡ 30
350 ¡ 40
160 ¡ 20
240 ¡ 40
380 ¡ 40
400 ¡ 50

26 ¡ 6
26 ¡ 8
27 ¡ 9
80 ¡ 40
100 ¡ 20
110 ¡ 30
120 ¡ 30
90 ¡ 30
180 ¡ 50
170 ¡ 70
200 ¡ 60
230 ¡ 70
200 ¡ 100
240 ¡ 60
270 ¡ 73
250 ¡ 90
300 ¡ 100
270 ¡ 60
300 ¡ 60

3¡1
3¡1
4¡1
11 ¡ 5
16 ¡ 3
18 ¡ 4
18 ¡ 4
14 ¡ 4
26 ¡ 7
30 ¡ 10
30 ¡ 10
40 ¡ 10
40 ¡ 20
38 ¡ 9
40 ¡ 10
40 ¡ 10
50 ¡ 20
40 ¡ 10
50 ¡ 10
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Fig. 5 (a) Tangent modulus (20%–30% strain) and (b) compressive stress at
failure for typical Gelapin-4/14.6 hydrogels as a function of mass loss during
proteolytic degradation. Arrows indicate trend with mass loss.
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4. Conclusions
We successfully prepared genipin cross-linked gelatin hydrogel materials which were characterised in terms of extent of
cross-linking, swelling behaviour, degradability and mechanical characteristics as well as ability for vascularization. It was
shown that soaking Gelapin in phosphate buffered saline
solution (37 uC, pH 7.4) for 72 h resulted in the removal of 99%
of the leachable gelatin and genipin. The swelling behaviour,
mechanical properties and degradability of these hydrogels
can be controlled through adjustment of the genipin and the
gelatin concentrations. The degradation rate could be tuned
between 50 mg per day and 500 mg per day. Compressive
stress at strain value could be tuned over one order of
magnitude (26 ¡ 6 kPa to 300 ¡ 60 kPa). Proteolytic
degradation studies showed that typical Gelapin hydrogels
became more ductile and elastic until they degraded by more
than 70% (by mass). It was shown that typical Gelapin
hydrogels have the ability to become vascularised with
incorporation of pro-angiogenic factors. This paper contributes to the development of Gelapin hydrogels as a potential
material for use in future tissue engineering applications.
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